Yaping Huang
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 23, 2026
Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database.Maohua Chen, Chengjie Ke, Yaping Huang
|Feb 26, 2026
Safety assessment of frunevetmab for osteoarthritis pain in cats: disproportionality analysis of the Food and Drug Administration Animal Drug Adverse Events database.Xiaoheng Lai, Li Lin, Yan Chen
|Jul 27, 2025
Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.Yaping Huang, Chengjie Ke, Maohua Chen
|Sep 21, 2024
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.Chengjie Ke, Maohua Chen, Li Lin
|Jun 15, 2024
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer.Yaping Huang, Chengjie Ke, Jiaqin Cai
Pageof 1
